Skip to main content
OpenTrials

Clinical trial condition

Visual Impairment Due to Choroidal Neovascularization (CNV) Secondary to Pathologic Myopia (PM)

Explore clinical trials studying Visual Impairment Due to Choroidal Neovascularization (CNV) Secondary to Pathologic Myopia (PM). Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Visual Impairment Due to Choroidal Neovascularization (CNV) Secondary to Pathologic Myopia (PM) trial results

Completed

Efficacy and Safety of Ranibizumab 0.5 vs Verteporfin PDT in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia

NCT01922102

Conditions
Choroid Diseases, Choroidal Neovascularization, Eye Diseases, +6 more
Locations
  • Novartis Investigative Site Beijing, Beijing Municipality, China
  • Novartis Investigative Site Beijing, Beijing Municipality, China
  • Novartis Investigative Site Chongqing, Chongqing Municipality, China
  • Novartis Investigative Site Shantou, Guangdong, China
View all 47 locations
View Trial Details

Related conditions